SCHEMBL9948612

SCHEMBL9948612

CCC(=O)Nc1n[c]ncn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.40
ADORA2A P29274 6/20 0.40
ADORA1 P30542 5/20 0.40
ADORA2B P29275 4/20 0.40
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 2/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
TSHR P16473 1/20 0.35
POLB P06746 2/20 0.34
ATM Q13315 1/20 0.34
GAA P10253 1/20 0.34
TP53 P04637 1/20 0.34
NR4A1 P22736 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9948617 0.80 LMNA (0.46) ADORA3ADORA2AADORA1ADORA2BKMT2A
SCHEMBL17451125 0.76 ADORA3 (0.49) ADORA3ADORA2AADORA1ADORA2BKMT2A
SCHEMBL4409751 0.70 LMNA (0.68) ADORA3ADORA2AADORA1ADORA2BKMT2A
SCHEMBL7168077 0.69 ADORA3 (0.40) ADORA3ADORA2AADORA1ADORA2BRAB9A
SCHEMBL864298 0.69
SCHEMBL3295899 0.68 ADORA3 (0.56) ADORA3ADORA2AADORA1ADORA2BKMT2A
SCHEMBL19151157 0.67 ADORA3 (0.50) ADORA3ADORA2AADORA1ADORA2BLMNA
SCHEMBL19150987 0.67 LMNA (0.44) ADORA3ADORA2AADORA1ADORA2BKMT2A
SCHEMBL6169811 0.66 CCNK (0.46) ADORA3ADORA2AADORA1ADORA2BKMT2A
SCHEMBL25948055 0.66 ADORA3 (0.45) ADORA3ADORA2AADORA1ADORA2BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165334-A1 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors AMGEN INC. (US) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165334-A1 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors MTOR, PIKFYVE, RICTOR ADORA3 3744/4885ADORA2A 3977/4885ADORA1 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.